Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2014 Oct 5;1(1):15-7.
doi: 10.1016/j.jdcr.2014.10.002. eCollection 2015 Jan.

Interferon beta-1a-induced morphea

Spencer A Bezalel  1 , Bruce E Strober  2 , Katalin Ferenczi  3
Affiliations
Case Reports

Interferon beta-1a-induced morphea

Spencer A Bezalel et al. JAAD Case Rep. .
No abstract available

Keywords: IFN-β, Interferon beta; IFN-β1a, Interferon beta-1a; IL-4, Interleukin 4; MS, Multiple sclerosis; SSc, Systemic sclerosis; Th2, T helper 2; injection site reaction; interferon beta-1a; morphea; multiple sclerosis.

PubMed Disclaimer

Figures

Fig 1
Fig 1
Depressed, indurated, bound-down hyperpigmented plaques involving anterior thighs (A) and right hip (B).
Fig 2
Fig 2
A, Punch biopsy from the right thigh shows thickened collagen bundles extending into the subcutaneous fat, paucity of adnexal structures, and a deep reticular lymphocytic infiltrate (Hematoxylin-eosin stain; original magnification: ×4). B, Higher magnification image shows thickened collagen, lymphoplasmacytic infiltrate, and entrapment of the eccrine glands by collagen (original magnification: ×20).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Walther E.U., Hohlfield R. Multiple sclerosis: Side effects of interferon beta therapy and their management. Neurology. 1999;53:1622–1627. - PubMed
    1. Hugle T., Gratzl S., Daikeler T., Frey D., Tyndall A., Walker U.A. Sclerosing skin disorders in association with multiple sclerosis. Coincidence, underlying autoimmune pathology, or interferon induced? Ann Rheum Dis. 2009;68:47–50. - PubMed
    1. Fett N., Werth V.P. Update on morphea. J Am Acad Dermatol. 2011;64:217–228. - PubMed
    1. Sartori-Valinotti J., Tollefson M.M., Reed A.M. Updates on Morphea: Role of Vascular Injury and Advances in Treatment. Autoimmune Dis. 2013;2013:1–8. - PMC - PubMed
    1. Grabell D., Clifford H., Andrew R. The role of skin trauma in the distribution of morphea lesions: A cross-sectional survey of the Morphea in Adults and Children cohort IV. J Am Acad Dermatol. 2014;71:493–498. - PMC - PubMed

Publication types

LinkOut - more resources